Shares of Regulus Therapeutics (NASDAQ:RGLS) spiked on Thursday after the microRNA-focused drug developer announced ...

Specifically, its technology is based on testing the patient’s blood for the presence of microRNA — tiny molecules which play a role in switching genes on or off. Afynia’s microRNA test ...

TransCode Therapeutics (RNAZ) announced that the first patient in Cohort 4 of its Phase I clinical trial has received their initial dose.

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the first patient in Cohort 4 of its ...

A DNA nanomachine selectively targets skin cancer by detecting microRNA-7, activating phototherapy and releasing chemotherapy ...

Abnormal expression and function of microRNA-203 have been linked to various autoimmune diseases, including rheumatoid arthritis and psoriasis. In a new study, researchers investigated microRNA-203 as ...

Cornell researchers have confirmed that a previously identified biomarker for detecting the presence of malignant testicular germ cell tumors has the potential to improve patient outcomes through ...

The following is a summary of “Identification of hypertension subtypes using microRNA profiles and machine learning,” ...

Victor Ambros and Gary Ruvkun won this year’s Physiology or Medicine award for the discovery of microRNA and its role in post-transcriptional gene regulation. Danielle is a Senior Editor at The ...

By integrating qRT-PCR with the SVM algorithm, this study introduces a novel technological approach for identifying gutter oil based on microRNA abundance, offering a powerful tool for ensuring ...

“The microRNA fraction is less complex,” he says, “but that doesn't mean you can get away with a poor experimental design or fewer replicates.” The obvious solution is to verify results ...